| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.957 | 0 | 1.982 | 3.691 | 4.927 | 5.739 | 8.919 | 39.014 |
| Total Income - EUR | - | - | 1.957 | 0 | 2.062 | 3.691 | 4.927 | 5.739 | 8.919 | 56.407 |
| Total Expenses - EUR | - | - | 4.117 | 0 | 1.935 | 3.295 | 2.104 | 2.515 | 15.534 | 52.706 |
| Gross Profit/Loss - EUR | - | - | -2.160 | 0 | 126 | 396 | 2.822 | 3.223 | -6.614 | 3.701 |
| Net Profit/Loss - EUR | - | - | -2.197 | 0 | 64 | 318 | 2.822 | 3.107 | -6.704 | 3.125 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Vero Profyline Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 623 |
| Current Assets | - | - | 345 | 339 | 86 | 99 | 1.467 | 5.166 | 1.183 | 13.783 |
| Inventories | - | - | 48 | 47 | 0 | 0 | 18 | 0 | 378 | 11.103 |
| Receivables | - | - | 42 | 41 | 40 | 40 | 76 | 39 | 39 | 0 |
| Cash | - | - | 255 | 250 | 45 | 59 | 1.373 | 5.127 | 766 | 2.680 |
| Shareholders Funds | - | - | -2.153 | -2.114 | -2.008 | -1.652 | 1.206 | 4.317 | -2.399 | 739 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.498 | 2.452 | 2.094 | 1.752 | 261 | 849 | 3.583 | 13.667 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Vero Profyline Srl